Ritter Pharmaceuticals Inc (RTTR)

[Tadaaa]

RTTR FDA Phase 3 Clinical Trial Update: "The LI symptom composite score includes abdominal pain, abdominal bloating, abdominal cramping, and abdominal gas"

Looks like they expanded the study to include additional composite scores, which is a good thing since Management believes that their solution can address other Gastrointestinal issues......GLTA !!

https://www.clinicaltrials.gov/ct2/show/NCT03597516?term=NCT03597516&rank=1